Skip to main content

Advertisement

Log in

The effect of the number of biopsies on the delay in the time from the delivery of mammography results to breast cancer histopathological diagnosis

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

The delay in the time (in calendar days) from the delivery of mammography results to histopathological breast cancer (BC) diagnosis could be associated with more advanced clinical stages, a worse prognosis and higher mortality. Therefore, we assessed the association between the number of biopsies and the delay in the time (in calendar days) from the delivery of mammography results to histopathological BC.

Methods

A survey was performed on 563 women aged between 35 and 69 years with histopathologically confirmed BC who attended 11 Mexican hospitals.

Results

After adjusting for potential confounders, the odds of having a delay in the time (in calendar days) from the delivery of mammography results to histopathological BC diagnosis (≥ 60 days) among women with ≥ 3 biopsies were 2.99 times the odds of those who had only one biopsy (95% CI 1.35, 6.63).

Conclusion

The number of biopsies should be considered as a predictor of the time delay between the delivery of the mammography result and the diagnostic result.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.”

References

  1. Facione NC (1993) Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 36(12):1521–1534. https://doi.org/10.1016/0277-9536(93)90340-a

    Article  CAS  PubMed  Google Scholar 

  2. Weller D, Vedsted P, Rubin G et al (2012) The Aarhus statement: Improving design and reporting of studies on early cancer diagnosis. Br J Cancer 106(7):1262–1267. https://doi.org/10.1038/bjc.2012.68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Coxon D, Campbell C, Walter FM et al (2018) The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments. BMC Health Serv Res 18(1):1–9. https://doi.org/10.1186/s12913-018-3476-0

    Article  Google Scholar 

  4. Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E et al (2016) Effect of care-delivery delay on the survival of Mexican women with breast cancer. Salud Publica Mex 58(2):237–250. https://doi.org/10.21149/spm.v58i2.7793

  5. Unger-Saldaña K, Ventosa-Santaulària D, Miranda A et al (2018) Barriers and explanatory mechanisms of delays in the patient and diagnosis intervals of care for breast cancer in Mexico. Oncologist 23(4):440–453. https://doi.org/10.1634/theoncologist.2017-0431

    Article  PubMed  Google Scholar 

  6. Dianatinasa M, Fararouei M, Mohammadianpanah M et al (2016) Impact of social and clinical factors on diagnostic delay of breast cancer A Cross-sectional Study. Med (Baltimore) 95(38):e4704. https://doi.org/10.1097/MD.0000000000004704

    Article  Google Scholar 

  7. Foroozani E, Ghiasvand R, Mohammadianpanah M et al (2020) Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in Iran: a multi-center study. Sci Rep 10(1):21477. https://doi.org/10.1038/s41598-020-78517-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. NORMA Oficial Mexicana NOM-041-SSA2-2011 (2011) Para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Diario Oficial de la Federación. http://www.cenetec.salud.gob.mx/descargas/equipoMedico/normas/NOM_041_SSA2_2011.pdf

  9. Unger-Saldaña K (2014) Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol 5(3):465–477. https://doi.org/10.5306/wjco.v5.i3.465

    Article  PubMed  PubMed Central  Google Scholar 

  10. Unger-Saldaña K, Infante-Castañeda C (2009) Delay of medical care for symptomatic breast cancer: a literature review. Salud Publica Mex 51(2):270–285. https://doi.org/10.1590/s0036-36342009000800018

    Article  Google Scholar 

  11. Olarewaju SO, Oyekunle EO, Bamiro AO (2019) Effect of sociodemographic variables on patient and diagnostic delay of breast cancer at the foremost health care institution in Nigeria. J Glob Oncol 5:1–8. https://doi.org/10.1200/JGO.19.00108

    Article  PubMed  Google Scholar 

  12. Neave LM, Mason BH, Kay RG (1990) Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat 15(2):103–108. https://doi.org/10.1007/BF01810782

    Article  CAS  PubMed  Google Scholar 

  13. Medeiros GC, Thuler LCS, Bergmann A (2021) Determinants of delay from cancer diagnosis to treatment initiation in a cohort of Brazilian women with breast cancer. Heal Soc Care Commun. https://doi.org/10.1111/hsc.13284

    Article  Google Scholar 

  14. Abdel-Fattah MM, Anwar MA, Mari E et al (1999) Patient- and system-related diagnostic delay in breast cancer. Eur J Public Health 9(1):15–19. https://doi.org/10.1093/eurpub/9.1.15

    Article  Google Scholar 

  15. Unger-Saldaña K, Miranda A, Zarco-Espinosa G et al (2015) Health system delay and its effect on clinical stage of breast cancer: multicenter study. Cancer 121(13):2198–2206. https://doi.org/10.1002/cncr.29331

    Article  PubMed  Google Scholar 

  16. Symonds RP (2002) Cancer biology may be more important than diagnostic delay. Br Med J 325(7367):774

    Article  Google Scholar 

  17. Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087. https://doi.org/10.1136/bmj.m4087

    Article  PubMed  Google Scholar 

  18. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112:S92-107. https://doi.org/10.1038/bjc.2015.48

    Article  PubMed  PubMed Central  Google Scholar 

  19. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119–1126. https://doi.org/10.1016/s0140-6736(99)02143-1

    Article  CAS  PubMed  Google Scholar 

  20. González Block M, Reyes Morales H, Hurtado LC et al (2020) Mexico: health system review. Health Syst Transit 22(2):1–222

    PubMed  Google Scholar 

  21. Ángeles-Llerenas A, Ortega-Olvera C, Pérez-Rodríguez E et al (2010) Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 21(4):577–586. https://doi.org/10.1007/s10552-009-9487-8

    Article  PubMed  Google Scholar 

  22. Hernan M (2020) Causal inference book. Harvard T.H. Chan School of Public Health 21–23. https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/

  23. Hukkinen K, Kivisaari L, Heikkilä PS et al (2008) Unsuccessful preoperative biopsies, fine needle aspiration cytology or core needle biopsy, lead to increased costs in the diagnostic workup in breast cancer. Acta Oncol (Madr) 47(6):1037–1045. https://doi.org/10.1080/02841860802001442

    Article  Google Scholar 

  24. Mohar A, Bargalló E, Ramírez MT et al (2009) Recursos disponibles para el tratamiento del cáncer de mama en México. Salud Publica Mex 51(SUPPL.2):263–269. https://www.saludpublica.mx/index.php/spm/article/view/4895/4743

  25. Santiago L, Adrada BE, Huang ML et al (2017) Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. Breast Cancer Res Treat 166(1):29–39. https://doi.org/10.1007/s10549-017-4401-7

    Article  CAS  PubMed  Google Scholar 

  26. Liebens F, Carly B, Cusumano P et al (2009) Breast cancer seeding associated with core needle biopsies: a systematic review. Maturitas 62(2):113–123. https://doi.org/10.1016/j.maturitas.2008.12.002

    Article  PubMed  Google Scholar 

  27. Youngson BJ, Liberman L, Rosen PP (1995) Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103(5):598–602. https://doi.org/10.1093/ajcp/103.5.598

    Article  CAS  PubMed  Google Scholar 

  28. Phelan SM, O’Doherty A, Hill A et al (2007) Epithelial displacement during breast needle core biopsy causes diagnostic difficulties in subsequent surgical excision specimens. J Clin Pathol 60(4):373–376. https://doi.org/10.1136/jcp.2006.036996

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ginsburg O, Yip CH, Brooks A et al (2020) Breast cancer early detection: a phased approach to implementation. Cancer 126(Suppl 10):2379–2393. https://doi.org/10.1002/cncr.32887

    Article  PubMed  Google Scholar 

  30. Ellis IO, Humphreys S, Michell M et al (2004) Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 57(9):897–902. https://doi.org/10.1136/jcp.2003.010983

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chala L, Endo E, Kim S et al (2007) Gray-scale sonography of solid breast masses: diagnosis of probably bening masses and reduction of the number of biopsies. J Clin Ultrasound 35:9–19. https://doi.org/10.1002/jcu.20298

    Article  PubMed  Google Scholar 

  32. Tesfaw A, Demis S, Munye T et al (2020) Patient delay and contributing factors among breast cancer patients at two cancer referral centres in Ethiopia: a cross-sectional study. J Multidiscip Healthc 13:1391–1401. https://doi.org/10.2147/JMDH.S275157

    Article  PubMed  PubMed Central  Google Scholar 

  33. Montella M, Crispo A, Aiuto D, G, et al (2001) Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 10(1):53–59. https://doi.org/10.1097/00008469-200102000-00006

    Article  CAS  PubMed  Google Scholar 

  34. Romeiro Lopes TC, Gravena AAF, de Demitto M et al (2017) Delay in diagnosis and treatment of breast cancer among women attending a reference service in Brazil. Asian Pac J Cancer Prev 18(11):3017–3023. https://doi.org/10.22034/APJCP.2017.18.11.3017

    Article  PubMed  Google Scholar 

  35. Foerster M, McKenzie F, Zietsman A et al (2021) Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: findings from the multicountry ABC-DO cohort study. Int J Cancer 148(2):340–351. https://doi.org/10.1002/ijc.33209

    Article  CAS  PubMed  Google Scholar 

  36. Poum A, Promthet S, Duffy SW et al (2014) Factors associated with delayed diagnosis of breast cancer in Northeast Thailand. J Epidemiol 24(2):102–108. https://doi.org/10.2188/jea.je20130090

    Article  PubMed  PubMed Central  Google Scholar 

  37. Shahid S, Teng THK, Bessarab D et al (2016) Factors contributing to delayed diagnosis of cancer among Aboriginal people in Australia: a qualitative study. BMJ Open 6(6):e010909. https://doi.org/10.1136/bmjopen-2015-010909

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We acknowledge the support of the recruitment sites, as well as the women participating in this research. We particularly thank María Felix Lazcano López, Libia Zulema Franco Velázquez, and Silvia Cardoso Muñoz for participating in the recruitment process.

Funding

This work was funded by Centro Nacional de Equidad de Género y Salud Reproductiva.

Author information

Authors and Affiliations

Authors

Contributions

AGA, AALL, and GTM contributed to the conception and design of the work; AGA and COO acquired the data; AGA, LMG, JZRD, and GTM contributed to the writing of the first draft of the manuscript; AGA, GTM, AALL, and COO contributed to the critical review of the manuscript; LMG and JZRD contributed to the review of the literature.

Corresponding author

Correspondence to Gabriela Torres-Mejía.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

This study was approved by the ethical research committee of the Institution.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garduño-Alanis, A., Morales-González, L., Ángeles-Llerenas, A. et al. The effect of the number of biopsies on the delay in the time from the delivery of mammography results to breast cancer histopathological diagnosis. Cancer Causes Control 33, 1355–1361 (2022). https://doi.org/10.1007/s10552-022-01622-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-022-01622-6

Keywords

Navigation